Oncologic photodynamic therapy: basic principles, current clinical status and future directions D Van Straten, V Mashayekhi, HS De Bruijn, S Oliveira, DJ Robinson Cancers 9 (2), 19, 2017 | 994 | 2017 |
Nanobody-based cancer therapy of solid tumors M Kijanka, B Dorresteijn, S Oliveira, PMP van Bergen en Henegouwen Nanomedicine 10 (1), 161-174, 2015 | 312 | 2015 |
Tumor-specific uptake of fluorescent bevacizumab–IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study LE Lamberts, M Koch, JS de Jong, ALL Adams, J Glatz, MEG Kranendonk, ... Clinical Cancer Research 23 (11), 2730-2741, 2017 | 273 | 2017 |
Antibody or antibody fragments: implications for molecular imaging and targeted therapy of solid tumors KT Xenaki, S Oliveira, PMP van Bergen En Henegouwen Frontiers in immunology 8, 1287, 2017 | 258 | 2017 |
Targeting tumors with nanobodies for cancer imaging and therapy S Oliveira, R Heukers, J Sornkom, RJ Kok, PMPB en Henegouwen Journal of Controlled Release 172 (3), 607-617, 2013 | 246 | 2013 |
Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti–epidermal growth factor receptor nanobody S Oliveira, GAMS Van Dongen, MS Walsum, RC Roovers, JC Stam, ... Molecular imaging 11 (1), 7290.2011. 00025, 2012 | 220 | 2012 |
Crosstalk between epidermal growth factor receptor-and insulin-like growth factor-1 receptor signaling: implications for cancer therapy S Oliveira, RM Schiffelers, G Storm, PMP Henegouwen, RC Roovers Current cancer drug targets 9 (6), 748-760, 2009 | 219 | 2009 |
Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes S Oliveira, I van Rooy, O Kranenburg, G Storm, RM Schiffelers International journal of pharmaceutics 331 (2), 211-214, 2007 | 203 | 2007 |
Downregulation of EGFR by a novel multivalent nanobody-liposome platform S Oliveira, RM Schiffelers, J van der Veeken, R van der Meel, ... Journal of Controlled Release 145 (2), 165-175, 2010 | 170 | 2010 |
Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery M Kijanka, FJ Warnders, M El Khattabi, M Lub-de Hooge, GM van Dam, ... European journal of nuclear medicine and molecular imaging 40, 1718-1729, 2013 | 163 | 2013 |
EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer PBAA Van Driel, MC Boonstra, MD Slooter, R Heukers, MA Stammes, ... Journal of Controlled Release 229, 93-105, 2016 | 160 | 2016 |
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy M Talelli, S Oliveira, CJF Rijcken, EHE Pieters, T Etrych, K Ulbrich, ... Biomaterials 34 (4), 1255-1260, 2013 | 146 | 2013 |
Targeted delivery of siRNA S Oliveira, G Storm, RM Schiffelers BioMed Research International 2006 (1), 063675, 2006 | 143 | 2006 |
Reprint of" Nanobody—Shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting" M Talelli, CJF Rijcken, S Oliveira, R van der Meel, PMPB en Henegouwen, ... Journal of controlled release 153 (1), 93-102, 2011 | 139 | 2011 |
Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities RJC Fonseca, SNMCG Oliveira, FR Melo, MG Pereira, NMB Benevides, ... Thrombosis and Haemostasis 99 (03), 539-545, 2008 | 135 | 2008 |
Photochemical internalization enhances silencing of epidermal growth factor receptor through improved endosomal escape of siRNA S Oliveira, MM Fretz, A Høgset, G Storm, RM Schiffelers Biochimica et Biophysica Acta (BBA)-Biomembranes 1768 (5), 1211-1217, 2007 | 131 | 2007 |
Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting L Martínez-Jothar, S Doulkeridou, RM Schiffelers, JS Torano, S Oliveira, ... Journal of controlled release 282, 101-109, 2018 | 121 | 2018 |
Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment R Van Der Meel, S Oliveira, I Altintas, R Haselberg, J Van Der Veeken, ... Journal of controlled release 159 (2), 281-289, 2012 | 113 | 2012 |
Nanobody–photosensitizer conjugates for targeted photodynamic therapy R Heukers, PMPB en Henegouwen, S Oliveira Nanomedicine: Nanotechnology, Biology and Medicine 10 (7), 1441-1451, 2014 | 110 | 2014 |
Preclinical and clinical evidence of immune responses triggered in oncologic photodynamic therapy: clinical recommendations I Beltrán Hernández, Y Yu, F Ossendorp, M Korbelik, S Oliveira Journal of clinical medicine 9 (2), 333, 2020 | 100 | 2020 |